<DOC>
	<DOCNO>NCT02789475</DOCNO>
	<brief_summary>An open-label , multiple-dose study evaluate pharmacokinetic drug-drug interaction amlodipine rosuvastatin healthy adult male subject .</brief_summary>
	<brief_title>DP-R212 Pharmacokinetic Study</brief_title>
	<detailed_description />
	<mesh_term>Hyperlipidemias</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>BMI 1829 sign inform consent form prior study participation Clinically significant disease Previously donate whole blood within 60 day component blood within 14 day Clinically significant allergic disease Taken IP trial within 90 day An impossible one participate clinical trial investigator 's decision include laboratory test result</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>